.
.
elizabeth loder, md, professor of neurology, harvard medical school; chief, division of headache, brigham & women's hospital.
.
.
.
another new drug in the migraine pipeline is lasmiditan. it works the same way as triptans. but unlike the triptans, it doesn't constrict
.
.
.
.jeffrey krasner is president of emerging biocommunications, which consults to early- and mid-stage life science companies.
.